MK-4334

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameMK-4334
Drug Alias NameMK-4334
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit modulators
TargetsNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsCognitive DysfunctionCognition DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme LLC
Inactive CompaniesN/A
Active IndicationsCognition Disorders
Inactive IndicationsCognitive DysfunctionAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A